Putting the brakes on an enzyme might rescue neurons that are dying due to a type of Parkinson's disease that's caused by a ...

Despite a significant improvement in symptoms, around 20% of patients discontinued treatment due to adverse events.

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

MJFF co-founder and CEO Deborah W. Brooks read a letter of gratitude from Michael J. Fox for the support of the mission from old and new friends.

Misbehaving T cells light up long before Parkinson’s symptoms show, zeroing in on vulnerable brain proteins. Their early ...

Researchers are using an advanced brain imaging method called MEG to understand why Parkinson’s drug levodopa doesn’t work equally well for everyone. By mapping patients’ brain signals before and ...

LJI scientists have discovered that T cells may help detect Parkinson's disease years before motor symptoms appear. Your T ...

As Congress works to set funding levels for the National Institutes of Health, several advocacy groups for Parkinson’s disease research and initiatives are calling on lawmakers to ensure robust ...